Original Article

Characteristics of Radiopharmaceutical Uptake in Primary Tumor and Metastatic Lesions of Prostate Carcinoma: Comparison of Oligometastatic with Multimetastatic Disease
  • Gonca Kara Gedik
  • Farise Yılmaz
  • Hasan Önner
Mol Imaging Radionucl Ther 2023; 32: 20-27 DOI: 10.4274/mirt.galenos.2022.71463 PMID:36817826
Care Pathway at a Cancer Center for the Administration of Radiometabolic Therapy with 177Lu-PSMA in Patients with Metastatic Castration-resistant Prostate Cancer
  • Carlos Avila
  • Tatiana Cadavid
  • Maria Cristina Martínez
  • Humberto Varela
  • Nathalie Hernández-Hidalgo
Mol Imaging Radionucl Ther 2024; 33: 28-37 DOI: 10.4274/mirt.galenos.2023.82653 PMID:38390762

Original Research

In Vitro Evaluation of Tc-99m Radiopharmaceuticals for Gastric Emptying Studies
  • Türkan Ertay
  • Amet Semih Doğan
  • Özden Ülker
  • Hatice Durak
Mol Imaging Radionucl Ther 2014; 23: 21-24 DOI: 10.4274/Mirt.75047 PMID:24653931
Radiation Levels from Toilets Used By Patients Injected with 99mTc-based Radiopharmaceuticals in Ibadan
  • John Enyi Ejeh
  • Tolulope Hadrat Abiodun
  • Kayode Solomon Adedapo
  • Yetunde Ajoke Onimode
  • Olusegun Akinwale Ayeni
Mol Imaging Radionucl Ther 2014; 23: 60-63 DOI: 10.4274/mirt.82905 PMID:24963447